Sleep Disorders Trial, Recruiting NCT07446634 Sponsor: Jani Talvilahti Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07446634
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been clinically diagnosed with obstructive sleep apnea (a condition where breathing repeatedly stops during sleep) with a severity score of 15 or more events per hour.
  • People who live in or are registered as residents in Dalarna County.
  • People with a body mass index (a measure of body weight relative to height) between 15 and 35.
  • People for whom CPAP therapy (a breathing mask worn during sleep) and mandibular advancement therapy (a mouthguard-type device worn during sleep) have both been tried and have not worked.

Who may not be able to join:

  • People who have medical conditions that make general anaesthesia unsafe for them.
  • People whose overall physical health is rated as severely compromised or worse under a standard medical classification system used by anaesthesiologists (confirm with trial site).
  • People who have central sleep apnea, which is a different type of sleep apnea caused by the brain rather than a blocked airway.
  • People who have narcolepsy (a condition causing sudden, uncontrollable episodes of sleep).
  • People who have previously had jaw repositioning surgery (orthognathic surgery).
  • People with a history of tumour disease or radiotherapy involving the jaw area.
  • People with certain other health conditions linked to a higher risk of sleep apnea, including: an underactive thyroid (hypothyroidism), acromegaly (a hormonal condition causing abnormal growth), diabetes, active widespread rheumatoid arthritis, a diagnosed movement disorder affecting the limbs during sleep, or restless legs syndrome.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andreas Thor, Professor, Department of Surgical Sciences, Oral and Maxillofacial Surgery, Uppsala University, Uppsala, Sweden.

Phone: +46 23 49 21 08

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jani Talvilahti
Registry
ClinicalTrials.gov
Start date
6 February 2014
Est. completion
30 June 2031

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Apnea Hypopnea Index (AHI/h)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov